












































Insulin resistance precedes and is a hallmark of type II 
diabetes [1].  Despite decades of progress in under-
standing insulin-mediated signal transduction, the 
molecular mechanisms underlying insulin resistance are 
complex, and are not fully explored.  The onset of insulin 
resistance is correlated with increased flux through the 
hexosamine biosynthetic pathway that leads to elevated 
UDP-N-acetylglucosamine (GlcNAc) from a glycolysis 
intermediate  in  mammalian  cells [2].   UDP-GlcNAc  is  
 
 










































the donor for the post-translational modification of 
nuclear and cytosolic proteins through the addition of an 
O-linked GlcNAc molecule to serine and threonine 
residues [3].  Metazoa have conserved O-GlcNAc 
transferase (OGT) and O-GlcNAcase (OGA) enzymes 
that catalyze the addition and removal of O-GlcNAc, 
respectively.  O-GlcNAc cycling occurs in both the 
nucleus and cytoplasm, and numerous proteins have been 
reported to be O-GlcNAc modified including 
transcription factors, metabolic enzymes, and kinases (re-





































stress  resistance.  We  performed  an  affinity  purification  of  O‐GlcNAc‐modified  proteins  and  observed  that  a  high
percentage  of  these  proteins  are  regulated  by  insulin  signaling  and/or  impact  insulin  pathway  functional  outcomes,
suggesting  that  the  O‐GlcNAc  modification may  control  downstream  effectors  to  modulate  insulin  pathway  mediated
cellular processes. 
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in mammalian systems to induce insulin resistance.   
Aberrant O-GlcNAc modification is implicated in human 
diabetes, and age related neurodegenerative diseases [5-
7]. 
 
In  C. elegans, the conserved insulin-like signaling 
pathway regulates lifespan as well as reproductive 
development, stress response, and dauer formation [8, 9].  
Upon insulin binding, the insulin receptor (DAF-2) 
catalyzes receptor tyrosine phosphorylation events to 
activate phosphatidylinositol-3 kinase (PI3K/AGE-1) 
[10].  AGE-1 activates the effector kinases, AKT-1 and 
SGK-1, which antagonize the forkhead box O (FoxO) 
transcription factor DAF-16 by preventing its nuclear 







































diated signaling allows DAF-16 to localize to the nucleus 
where it regulates a large number of genes essential for 
metabolism, energy storage, reproductive development, 
immunity, stress resistance, and other novel processes 
which collectively modulate lifespan in C. elegans [11-
13].  Adult lifespan extension upon reduction in insulin 
signaling has also been reported in Drosophila, mice, and 
recently in a centenarian human population [14, 15].   
DAF-16 function is controlled by additional mechanisms 
beyond its nuclear localization, as neither constitutive 
nuclear localization nor over-expression is sufficient to 
induce maximum lifespan extension [16].  The 
mechanism by which insulin signaling mediated through 
FoxO/DAF-16 produces distinct biological outcomes in 
response to varying levels of insulin signaling remains 
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ogt-1, and a single OGA ortholog, oga-1.  In the current 
study we demonstrate that the O-GlcNAc cycling 
enzymes modulate median adult lifespan in C. elegans.  
Intriguingly, we delineate downstream functions of the 
insulin signaling pathway that are O-GlcNAc dependent, 
and others that appear to be O-GlcNAc independent.   
Finally we used a biochemical approach to identify 
putative O-GlcNAc target proteins, and found that the 
majority of these proteins are regulated by insulin 
signaling, and a significant percentage functionally 
impact lifespan.  Our work therefore suggests a potential 
mechanism by which the post-translational O-GlcNAc 
modification of proteins downstream of the insulin 





Cellular O-GlcNAc levels modulate adult lifespan in 
C. elegans 
 
In  C. elegans, O-GlcNAcase (oga-1) and O-GlcNAc 
transferase (ogt-1) homozygous null mutants are viable 
and appear overtly wild type [18, 19].  However, we 
observed that oga-1(ok1207) null mutant adults live 
~33% longer than the wild-type animals, while ogt-
1(ok1474) null mutants have a lifespan ~20% shorter 
than the wild type at 20°C (Figure 1A).  In C. elegans, 
movement ability is used as a general index of vitality 
[20].  The ogt-1 mutant animals appear to age 
prematurely, as exemplified by markedly slower 
movement at day 12 of adulthood relative to still-active 
wild-type and oga-1 mutant adults (Suppl. Movie 1).   
ogt-1 null mutant animals have normal developmental 
timing (43 ± 3.9 hrs vs. 41 ± 0.7 hrs for ogt-1 and wild 
type, respectively, p = not significant, >0.5), and generate 
fertile progeny numbers similar to wild-type animals 
(263  ± 80 vs. 289 ±  32 for ogt-1 and wild type, 
respectively, p = ns), suggesting that the reduced 
movement and earlier death of ogt-1 mutant adults is not 
due to a general ‘sickness’.  The oga-1(ok1207) mutant 
demonstrates a substantial increase in O-GlcNAc-
modified protein levels as determined by immunoblot of 
whole animal lysate, while the ogt-1(ok1474) mutant has 
only residual staining (Figure 1B).  To determine whether 
adult lifespan extension in oga-1 mutants arises from 
excessive O-GlcNAc-modifications, we analyzed the 
lifespan of the oga-1; ogt-1 double mutant which has a 
markedly reduced level of O-GlcNAc-modified proteins 
similar to the ogt-1 mutant (data not shown).  The adult 
lifespan of the oga-1; ogt-1 double mutant is similar to 
that of wild type (Table 1), confirming that lifespan 
extension observed in oga-1 mutants is dependent on 
excessive O-GlcNAc-modified protein levels.  
O-GlcNAc cycling enzymes modulate insulin-
mediated signaling in C. elegans 
 
Inactivation of insulin-mediated signaling increases C. 
elegans adult lifespan in a DAF-16-dependent manner 
[21].  We observed that the lifespan extension in the oga-
1(ok1207) mutant is also dependent on intact DAF-16 
(Figure 1C).  Inactivation of OGT-1 function in daf-
2(e1370) mutants dramatically reduces its adult lifespan 
arguing that O-GlcNAc modification of cellular proteins 
is a requirement for the daf-2 mutant long lifespan 
(Figure 1D).  Lifespan extension regulated by insulin-
mediated signaling in C. elegans is mainly achieved 
through its downstream effector kinases, such as AGE-1 
and SGK-1 (Figure 6).  Inactivation of the effector 
kinases AGE-1 and SGK-1 also results in significant 
adult lifespan extension [22, 23].  To further test whether 
O-GlcNAc modification is essential for insulin signaling 
mediated adult lifespan regulation, we inactivated O-
GlcNAc transferase function in both the long-lived age-
1(hx546) and sgk-1(ok538) mutants.  We observed that 
adult lifespan extension in age-1 and sgk-1 mutants are 
completely suppressed to wild-type levels upon 
combination with the short-lived ogt-1(ok1474) mutant 
allele (Figure 2A and 2B).   
 
In a conventional genetic analysis, genes that function in 
parallel pathways with the same functional output 
generally demonstrate additive interactions.  However, 
combining the long-lived oga-1(ok1207) mutant allele 
with long-lived insulin signaling pathway mutants, daf-2, 
age-1, or sgk-1, did not extend lifespan further, 
suggesting that O-GlcNAc-modified proteins function in 
the same genetic pathway (Figure 2C and 2D, Table 1).  
To further investigate where O-GlcNAc cycling impinges 
on the insulin signaling pathway, we analyzed both akt-1 
and  pdk-1 gain-of-function (gf) mutant alleles that 
constitutively activate the insulin signaling pathway [24, 
25].  Both akt-1(mg144)gf and pdk-1(mg142)gf mutant 
lifespans are shorter than that of wild type (Table 1).  The 
combination of akt-1(mg144)gf or pdk-1(mg142)gf 
mutant alleles with the long-lived oga-1(ok1207) allele 
failed to suppress the lifespan extension associated with 
the oga-1 mutant (Table 1).  This data suggests that O-
GlcNAc-modified proteins act downstream of the insulin 
pathway effector kinases to regulate insulin signaling 
outcomes.  However both mg144 and mg142 alleles also 
do not suppress the extended lifespan of the age-1(hx546) 
mutant [24]; and thus this conclusion is not definitive. 
 
In  C. elegans, the insulin signaling pathway regulates 
numerous biological functions through DAF-16 by 
restricting its nuclear localization including, dauer entry, 
longevity, stress resistance, fertility, and reproductive 
development [12].  We sought  to determine whether  per- 
   









































turbing the O-GlcNAc cycling enzymes OGT-1 or 
OGA-1 would affect DAF-16 subcellular localization.  
Inactivation of the insulin signaling pathway effector 
kinase AGE-1 (by RNAi) produced virtually complete 
nuclear localization of DAF-16 (Figure 3).   
Interestingly, inactivation of either OGA-1 or OGT-1 
produced a similar but modest increase in DAF-16 
nuclear localization (Figure 3).  The observation that 
inactivating either OGA-1 or OGT-1 produces similar 
effects on DAF-16 nuclear localization but opposite 
effects on insulin pathway outcomes, suggests that O-
GlcNAc cycling does not functionally modulate the 











































Perturbation in O-GlcNAc cycling affects only a 
subset of insulin-mediated functions 
 
Lifespan extension in insulin pathway mutants is 
correlated with oxidative and thermal stress resistance 
as well as changes in animal development [26, 27].  We 
observed that the long-lived oga-1 mutant is resistant to 
oxidative stress in a DAF-16-dependent manner similar 
to that observed with the daf-2 mutant (Figure 4A).  Co-
inactivation of OGT-1 and DAF-2 in daf-2(e1370); ogt-
1(ok1474) double mutant animals significantly reduced 
the oxidative stress resistance associated with the daf-2 
mutant (Figure 4A).  This data implies that protein O-
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In contrast to oxidative stress resistance, the long-lived 
oga-1 mutant differs from long-lived daf-2 mutants in 
that the oga-1 mutant does not exhibit increased 
thermal stress tolerance, delayed developmental timing 
defects, or reduced fecundity, which are prominent in 
daf-2 mutants (Figure 4B, 4C, and 4D, respectively) 
[16, 26, 28, 29].  Oxidative stress resistance in the 
insulin pathway mutants arises from the DAF-16-













































oxide dismutase SOD-3, while the increased 
thermotolerance is correlated with the induction of 
several heat-shock proteins, such as HSP-16 [27, 30, 
31].  We observed that the inactivation of OGA-1 
increased the expression of a sod-3::GFP reporter but 
not a hsp-16.2::GFP reporter (Figure 5A and 5B, 
respectively).  Our data indicates that O-GlcNAc 
modification of proteins is critical for only a subset of 
the insulin pathway functional outcomes that are 
















































Genotype      Median LS 
    ±STDEV 
p-value 
vs. wild type 
Sample size  
n(censored) 
Replicates   
N 
   Log-rank  Wilcoxon     
wild type  15.9±3.6  -  -  404(59)  8  
oga-1(ok1207)  20.9±4.1  <0.0001 <0.0001 317(43)  6   
ogt-1(ok1474)  12.9±1.9  <0.0001  <0.0001  306(64)  6  
oga-1(ok1207); ogt-1(ok1474)  15.5±4.9  0.030 0.040  174(35)  2   
daf-2(e1370)  28.6±3.5  <0.0001  <0.0001  235(26)  3  
oga-1(ok1207); daf-2(e1370)  21.6±0.6  <0.0001 <0.0001 201(20)  3   
ogt-1(ok1474); daf-2(e1370)  13.2±1.9  <0.0001  <0.0001  218(28)  3  
daf-16(mu86)  14.3±2.5  0.0001 <0.0001 228(60)  3   
oga-1(ok1207); daf-16(mu86)  14.8±1.8  0.019  0.009  173(25)  2  
ogt-1(ok1474); daf-16(mu86)  12.8±0.4  <0.0001 <0.0001 150(24)  2   
age-1(hx546)  25.6±4.1  <0.0001  <0.0001  216(18)  3  
oga-1(ok1207); age-1(hx546)  24.7±6.8  <0.0001 <0.0001 241(17)  3   
ogt-1(ok1474); age-1(hx546)  15.9±1.6  0.424  0.590  258(31)  3  
sgk-1(ok538)  29.8±3.2  <0.0001 <0.0001 235(16)  3   
oga-1(ok1207); sgk-1(ok538)  26.2±2.1  <0.0001  <0.0001  209(30)  3  
ogt-1(ok1474); sgk-1(ok538)  16.6±2.3  0.343 0.375  214(39)  3   
pdk-1(mg142)gf  14.8±1.7  0.013  0.007  334(84)  5  
oga-1(ok1207); pdk-1(mg142)  18.7±8.1
a  <0.0001 <0.0001 284(43)  5   
akt-1(mg144)gf  11.5±2.1  <0.0001  <0.0001  205(32)  2  
oga-1(ok1207); akt-1(mg144)  19.8±4.2




















































Identification of putative O-GlcNAc target proteins 
through affinity purification 
 
In an effort to identify the proteins that are modified by 
O-GlcNAc in C. elegans, we affinity purified O-GlcNAc-
modified proteins from oga-1(ok1207) and ogt-1(ok1474) 
mutant adults, and then identified the affinity purified 
proteins by liquid chromatography coupled to tandem 
mass spectrometry (LC-MS/MS).  Non-specific proteins 
would be expected to be present in both purifications, 
while O-GlcNAc-modified proteins (or proteins tightly-
associated with O-GlcNAc-modified proteins) would be 
specific for the oga-1 mutant lysate.  Proteins that were 
identified from affinity purifications of both oga-1 and 
ogt-1 mutant lysates were censored as non-specific.   
Using this approach, we identified 13 distinct proteins 
that were specific for the O-GlcNAc affinity purification 
from  oga-1 mutant lysate (Table 2).  The 13 proteins 
encompass a total of 21 proteins when including paralogs 
with identical or nearly identical protein sequences that 
could not be distinguished by mass spectrometry.  The 
majority of the putative O-GlcNAc target proteins are 
regulated by the insulin signaling pathway and a 
substantial percentage functionally modulate lifespan or 
oxidative stress (Table 2 and discussion below), 
suggesting that OGT-1 and OGA-1 may control a subset 
of insulin signaling functional outcomes by directly 
targeting the O-GlcNAc modification of proteins that act 




In  C. elegans, O-GlcNAc cycling enzyme mutants are 
viable and therefore provide a useful model to elucidate 
the role of O-GlcNAc protein modifications, which have 
been implicated in numerous cellular processes.  In our 
current study we demonstrated that a loss of O-GlcNAc 
transferase (OGT-1) activity reduces adult lifespan in the 
nematode  C. elegans.  Conversely, inactivation of O-
GlcNAcase (OGA-1) leads to a moderate increase in 
adult lifespan.  While the accumulation of excessive 
levels of O-GlcNAc-modified proteins in oga-1 mutant 
animals is associated with lifespan extension, it is not 
associated with obvious abnormalities in reproductive 
development, as oga-1 mutants have an overtly wild-type 
appearance, develop normally into adults, and generate 
normal numbers of fertile offspring.  Similarly, lifespan 
reduction in ogt-1 null mutants does not appear to be due 
to a general ‘sickness’ of the mutant animals, as ogt-1 
mutants also develop normally into fertile adults, and 
generate normal numbers of offspring (Figure 4).   
 
Love et al. recently reported similar results that OGT-1 
inactivation shortens both wild-type and daf-2 mutant 
lifespans [32].  However, their findings differ from ours 
in that they reported that OGA-1 inactivation did not 
significantly affect lifespan in a wild-type background 
but slightly extended lifespan in a daf-2 mutant 
background [32].  We observed that oga-1 mutant 
lifespan was significantly longer than that of wild type 
(three independent experiments showed significant 
differences; p<0.0001, n=66-89 for each experiment); 
and double mutant analysis of oga-1 with each of three 
separate components of the insulin signal transduction 
pathway, daf-2, age-1, and sgk-1, did not show additional 
lifespan increases in our experiments.  
Figure 3.  Aberrant protein O‐GlcNAc cycling modestly
enhances  DAF‐16  nuclear  localization.  DAF‐16::GFP
(translational fusion) nuclear localization in oga‐1(RNAi) and
ogt‐1(RNAi) animals is modestly increased relative to control
(vector)  RNAi  animals  but  much  less  than  observed  in  age‐
1(RNAi)  animals  (upper  panel).  Lower  panel  is  the
quantification  of  DAF‐16::GFP  levels  in  intestinal  cells  upon
RNAi inactivation of ogt‐1, oga‐1, age‐1, and vector control.  
   












































The failure to observe additive lifespan extension when 
combining  oga-1 and insulin pathway mutations is 
consistent with O-GlcNAc-modified proteins working in 
the same genetic pathway as insulin signaling.  In C. 
elegans, insulin signaling regulates gene expression by 
restricting DAF-16, whose activity is essential for the 
extended lifespan that is observed in insulin pathway 
mutants [11, 12].  We found that DAF-16 is required for 
the lifespan extension in oga-1 mutant animals, which is 
also consistent with O-GlcNAc cycling functioning in the 













































The observation that elevated O-GlcNAc levels (in the 
oga-1 mutant) mimics only a subset of insulin pathway 
mutant phenotypes (lifespan extension and resistance to 
oxidative stress) but not others (delayed developmental 
timing, reduced fecundity, and increased thermo-
tolerance) suggests that O-GlcNAc cycling only alters a 
subset of functional outcomes under the control of 
insulin-mediated signaling.  The insulin signaling 
pathway regulates DAF-16 nuclear localization.  If OGA-
1 and OGT-1 impacted the insulin pathway upstream of 
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localization.  However, we observed that both mutants 
have the same  modest  enhancement of DAF-16  nuclear 
localization, suggesting that O-GlcNAc cycling 














































We performed an affinity purification of O-GlcNAc-
modified proteins that identified 13 proteins (Table 2).  
The mammalian counterparts of 6 of the 13 proteins are 
known to be O-GlcNAc modified, suggesting that these 













































Strikingly, the expression of 10 of the 13 putative O-
GlcNAc target proteins is controlled by the insulin 
signaling pathway (Table 2).  More significantly, 4 of the 
13 putative O-GlcNAc target proteins have been reported 
to modulate lifespan in C. elegans.  Inactivation of either 
of the F0F1-type ATP synthases ATP-2 or H28O16.1 is 
observed to increase adult lifespan and increase the 
expression of a sod-3::GFP reporter [33].  Inactivation of 
the glyceraldehyde-3-phosphate dehydrogenase GPD-2 
further extends the lifespan of daf-2 mutants [34]; while 
inactivation of the malate dehydrogenase MDH-1 
Figure  5.  Aberrant  protein  O‐GlcNAc  cycling  differentially
affects  distinct  stress  response  pathways  in  C.  elegans.  (A)
Images  and  quantification  of  sod‐3::GFP  reporter  expression
upon  inactivation  of  OGA‐1  and  the  insulin  pathway  effector
kinase AGE‐1.  (B) Images and quantification of hsp‐16‐2::GFP






regulates  numerous  functions  including  stress  response,
metabolism, dauer formation, and reproductive development
by  restricting  the  nuclear  localization  of  the  DAF‐16/FoxO
transcription  factor  upon  nutrient  availability  [45].  Upon




(bottom  panel)  DAF‐16  enters  the  nucleus  and  regulates  the
expression  of  target  genes  to  mediate  numerous  DAF‐16
dependent processes, including those listed.  
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inactivation of GPD-2 and GPD-3 allows the daf-2 
(e1370) mutant to escape dauer entry, thereby 
demonstrating a critical role for GPDs in regulating one 
of the functional outcomes under the control of the 
insulin signaling pathway [36].  Our work therefore 
demonstrates that downstream targets of the insulin 
pathway are O-GlcNAc modified.  This provides the 
possibility that O-GlcNAc cycling enzymes act 
downstream of DAF-16 to directly functionally modulate 
specific insulin-regulated processes. 
 
In mammals, increasing O-GlcNAc levels by reducing O-
GlcNAcase (OGA) activity or increasing O-GlcNAc 
transferase (OGT) activity leads to insulin resistance 
[37].  Increased O-GlcNAc levels inhibit insulin 
stimulated activation of AKT, and disrupt insulin-
mediated glucose transport in adipocytes demonstrating a 





































tion of insulin-mediated signaling functional outcomes.   
A reduced ability of insulin to activate glucose transport 
into cells, i.e., insulin resistance, is marked by high 
glucose and high insulin levels in circulating blood, and 
aberrant insulin-regulated gene functions [10].   
Abnormalities in carbohydrate and fat metabolism are 
characteristic of insulin-resistant tissues, and are 
implicated in elevated plasma sugar and fatty acid levels 
in patients with type II diabetes [38].  In C. elegans, 
similar disarray in carbohydrate and fat storage is 
observed in insulin pathway mutant animals [9].   
Previous studies also demonstrated abnormal 
carbohydrate and fat storage upon disruption of O-
GlcNAc cycling [18].  Therefore, O-GlcNAc 
deregulation in C. elegans is strikingly similar to the 
insulin-resistant phenotype previously described in 
mammalian studies despite the absence of a blood 
circulation system and the consequent need for blood 







































Proteins  Molecular Identity  Expression in daf-2 mutant  O-GlcNAc modified in       
vertebrate homologs 
PHI-37  F0F1-type ATP synthase  Downregulated [46]  NR 
ATP-2  F0F1-type ATP synthase  Downregulated [46]  NR 
MDH-1  Malate dehydrogenase  Downregulated [47]  MDH1 [7]                  
GPD-2, GPD-3  Glyceraldehyde-3-phosphate 
dehydrogenase, major isozyme 
Upregulated [48,49]  GAPDH [7,50]              
GPD-1, GPD-4  Glyceraldehyde-3-phosphate 
dehydrogenase, minor isozyme 
Downregulated [46]  GAPDH [7,50]              
EFT-3, EFT-4  Translation elongation factor 1 alpha  Downregulated [46]  EEF1AO [50]               
ACT-1, ACT-2, 
ACT-3, ACT-4 
Actin  Downregulated [46]  ACTG1 [7]                 
TBA-1, TBA-2, 
TBA-4 
Alpha tubulin  Downregulated [46]  TUBA1A [7]                
VIT-6  Vitellogenin  Downregulated [46]  NR 
VHA-13  Vacuolar protein translocating ATPase  NR  NR 
CDC-48.2  AAA-type ATPase  NR  NR 
F27D4.1  Electron transfer flavoprotein  NR  NR 
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O-GlcNAc modifications have on the target proteins that 
were identified in this study, and the functional 
significance of the modifications on specific insulin 
pathway outcomes.  Many of the O-GlcNAc targets 
appear to be conserved between nematodes and 
vertebrates, and it will be interesting in the future to 
determine whether O-GlcNAc cycling acts downstream 
of the insulin pathway in vertebrates to control subsets of 
FoxO-dependent processes.  The use of C. elegans as an 
amenable genetic model will allow a fuller exploration of 
the complexities of O-GlcNAc modification and FoxO-
mediated gene expression, with implications for human 
neuro-degenerative diseases, diabetes, and developmental 
processes including aging. 
   
METHODS 
 
Nematode strains.  The following nematode strains were 
used in this study: N2 wild type Bristol, RB1342 ogt-
1(ok1474), RB1169 oga-1(ok1207), CF1041 daf-
2(e1370), CF1380 daf-16(mu86), TJ1052 age-1(hx546), 
VC345  sgk-1(ok538), GR1310 akt-1(mg144), GR1318 
pdk-1(mg142), and ET422 muIs109[Pdaf-
16::GFP::DAF-16 cDNA + Podr-1::RFP], CF1553 
muIs84[pAD76 (sod-3::GFP)], CL2070 dvls70[integrat-
ed hsp-16-2::GFP+pRF4], ET434 oga-1(ok1207), ET435 
ogt-1(ok1474), ET436 oga-1(ok1207);  ogt-1(ok1474), 
ET439  oga-1(ok1207);  daf-2(e1370), ET438 ogt-
1(ok1474);  daf-2(e1370), ET437 oga-1(ok1207);  daf-
16(mu86), ET468 ogt-1(ok1474); daf-16(mu86), ET469 
oga-1(ok1207);  age-1(hx546), ET393 ogt-1(ok1474); 
age-1(hx546), ET471 oga-1(ok1207);  sgk-1(ok538), 
ET470  ogt-1(ok1474);  sgk-1(ok538), ET472 oga-
1(ok1207);  pdk-1(mg142), and ET445 oga-1(ok1207); 
akt-1(mg144).  The oga-1(ok1207) and ogt-1(ok1474) 
mutants in strains ET434 and ET435 were outcrossed 6 
times against N2 in our laboratory with the mutations 
followed by PCR.  The mutation in ogt-1(ok1474) and 
oga-1(ok1207) alleles were verified using PCR primers 
provided by the C. elegans Gene Knockout Project at 
OMRF, which is part of the International C. elegans 
Gene Knockout Consortium.  The mutations in double 
mutant strains were followed by PCR and restriction 
enzyme analysis or by DNA sequencing spanning the 
region corresponding to the mutations, where 
appropriate. 
 
Lifespan analysis. All lifespan assays were performed 
using 85-125 animals for each genotype per assay at 
20°C on NGM plates seeded with OP50 bacteria 
following established procedures [8].  Adults were 
transferred to fresh plates every alternate day during the 
fertile period, and later when necessary.  Adults were 
counted as dead when they failed to respond to repeated 
head and tail prodding.  Multiple assays were pooled for 
final analysis. 
 
Statistical analyses.   Survival curves were analyzed by 
the Log-rank (Mantel-Cox) and Wilcoxon tests using 
GraphPad Prism (version 5.0) to determine the 
significance between mutant and wild-type controls as 
indicated in Table 1.  In other experiments, statistical 
significance was determined with the unpaired two-tailed 
Student’s t-test. 
 
Stress tolerance assay.  Oxidative stress resistance assays 
were performed in multi-well plates by immersing adults 
in M9 media containing 100 mM paraquat (N,N'-
dimethyl-4,4'-bipyridinium dichloride) using 10-20 
animals for each genotype per assay at 20°C [39, 40].  A 
complete absence of swimming movement was scored as 
death, and also reconfirmed by transferred animals not 
moving upon prodding on agar plates.  Death was scored 
every 3, 6, 9, and 12 hrs.  Experimental data from 
multiple assays were pooled together for final analysis.  
Thermal resistance assays were performed on NGM 
plates pre-heated at 35°C using at least 50 animals for 
each genotype per assay [29, 41].  Adults were incubated 
at 35°C, and were scored every hour by response to touch 
until all animals were dead.  Experimental data from 
multiple assays were pooled together for final analysis. 
 
Developmental timing and fecundity assays.  
Postembryonic developmental timing was assayed by 
collecting comma-stage embryos from animals 
maintained at 20°C.  The exact time of hatching was 
recorded, and then animals were transferred onto separate 
OP50-seeded NGM plates.  After the third molt, animals 
were inspected more frequently (every 15 mins) to record 
the exact time of the fourth molt.  The assay was repeated 
several times using at least 10 animals for each genotype 
per assay, and multiple experimental data were pooled 
together for final analysis.  For fecundity analysis, 
individual larval stage animals were placed on OP50-
seeded NGM plates at 20°C.  Offspring were counted by 
moving them onto a fresh plate one-by-one.  The assay 
was repeated multiple times with at least 10 animals per 
genotype in each assay, and data were pooled together for 
final analysis. 
 
Western immunoblotting.  Adult animals were flash 
frozen in liquid nitrogen in lysis buffer (50mM HEPES 
pH 7.8 and 300mM NaCl).  Frozen worms were crushed 
in a pestle pre-chilled with liquid nitrogen.  The frozen 
ground worms were re-suspended in cold lysis buffer 
(with DNaseI and protease inhibitor cocktail from Roche) 
and subjected to sonication for 6-8 seconds followed by 
centrifugation at 16,000 rpm for 1 hour at 4°C.  The 
middle portion (not including the pellet or floating lipids) 
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of whole animal lysate was separated on a 10% NuPAGE 
Bis-Tris gel (Invitrogen) followed by transfer onto a 
PVDF membrane (Millipore).  The membrane was 
probed with anti-O-GlcNAc antibody from Affinity 
Bioreagents (1:2000 in 3% BSA dissolved in 1XTBS + 
0.05% Tween20).  The immunoblot was visualized using 
a chemiluminescent substrate (Super Signal West Pico 
from Pierce).  The same membrane was re-probed with 
anti-α-tubulin antibody (Sigma) to normalize protein 
loading. 
 
RNAi experiments.  All RNAi experiments were 
performed at 20°C unless otherwise mentioned using E. 
coli strain HT115 transformed with pPD129.36 clones 
from an RNAi library provided by Julie Ahringer for 
gene inactivation experiments, as previously described 
[42, 43].  
 
GFP reporter assays.  Experimental animals for analysis 
were grown on feeding RNAi for more than one 
generation.  All animals were imaged at single shutter 
setting, and equal nuclear and cytoplasmic areas were 
chosen for light intensity measurement using OpenLab 
5.5 software.  The average of three mean light intensity 
measurement values per cell (in arbitrary units) for both 
nuclear and cytoplasmic regions were recorded for 
multiple cells in each treated and untreated animals.  The 
assay was repeated several times with at least 10 animals 
per genotype in each assay at 20°C.  Data from multiple 
experiments were pooled for final analysis.  Both sod-
3::gfp and hsp-16-2::gfp reporters were assayed in 10-
day-old adults. 
 
Affinity purification and identification of O-GlcNAc-
modified proteins.  Adult animals were collected and 
flash frozen in liquid nitrogen in 50mM HEPES pH 7.8 
and 50mM NaCl buffer.  Frozen worms were crushed 
with a mortar and pestle pre-chilled with liquid 
nitrogen.  The frozen ground worms were re-suspended 
in the above buffer (with DNaseI and protease inhibitor 
cocktail from Roche), and disrupted by sonication 
followed by centrifugation at 16,000 rpm for 1 hour at 
4°C.  Clear supernatant was collected and O-GlcNAc-
modified proteins were identified as previously 
described [44].  Briefly, affinity enrichment with 
mAb14 to O-GlcNAc-modified proteins was conducted 
followed by the enriched proteins being reduced, 
alkylated, and trypsin digested.  Protein assignments 
were made following tandem mass spectrometry on a 
linear ion trap using the C. elegans protein database 
from NCBI with filtering for a false-discovery rate of 
less than 1%, as previously described [44].  The number 
of peptides leading to the identification of each protein 
described in Table 2 are as follows: PHI-37 (8); MDH-1 
(7); ATP-2 (3); GPD-1 (2); GPD-2 (4); ACT-1 (5); 
TBA-2 (3); EFT-3 (6); VIT-6 (2); VHA 13 (2); CDC-
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Supplementary material is found online in full text 
version of this manuscript.  
 
Supplemental Movie 1.  Premature aging in animals 
lacking O-GlcNAc-modified proteins.  Three 10-
second movie recordings, from left to right, oga-
1(ok1207), wild type (N2), and ogt-1(ok1474) animals 
at day 12 of adulthood.  Note that, while oga-1 mutant 
and wild-type animals are highly active, the ogt-1 
mutant animal is considerably slower, a phenotype 
similar to that of older (day 18) wild-type animals (data 
not shown).  At an earlier time point (day 6) all three 
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